The Research for Associativity of ODC Genetic Expression with Lung Cancer in Vitro

蒋进皎,曹铭锋,王功朝,王洲

DOI: https://doi.org/10.3969/j.issn.1671-4008.2009.06.030

2009-01-01

Abstract:Objective To investigate the expression of ODC(ornithine decarboxylasc) mRNA in the lung cancer. Method Total RNA was extracted from 84 surgically resected specimens of lung cancers and normal tissue closed to the lesions. By the methods of RT -PCR and Western Blot, the mRNA expression and the protein levels of the ODC gene in the lesions and the normal tissue were examined, so the relation between these expression levels and clinical pathological index was compared.Moreover, The antisense RNA recombinant (pcDNA-ODCr) has been constructed and packaged to investigate the inhibittory action of the ODC antisense RNA to the growth of the lung cancer extracorporeally. Results RT-PCR showed that the expression of ODC gene mRNA in the lung cancer was significantly highter than that in contiguous normal tissue (P0.01); The difference of the expression of ODC gene mRNA in the pathological type and differentiated level was non-significant (P0.05); the difference in the clinical stage was statistically significant (P 0.01), and it was significantly higher in the lung cancer of the advanced stage than in the early stage (P0.01). Western Blot showed that the expression of ODC gene mRNA in the lung cancer was significantly higher than that in contiguous normal tissue. Extracorporeal research showed that the multiplication of the transinfection cells by the ODC antisense RNA was slower than the control group or the non-vector-transinfection cells. Conclusion ODC gene plays an important role in the tumorigenesis and infiltration of the lung cancer, and the ODC mRNA’s up -regulated expression is related to the clinical stage.